Temasek Holdings Private LTD Trimmed Its Position in Thermo Fisher Scientific (TMO) by $19.42 Million; As Hi (HCLP) Stock Price Declined, Oceanic Investment Management LTD Has Upped by $1.44 Million Its Holding

November 15, 2017 - By Maria Brooks

Oceanic Investment Management Ltd increased its stake in Hi (HCLP) by 34.24% based on its latest 2017Q2 regulatory filing with the SEC. Oceanic Investment Management Ltd bought 144,400 shares as the company’s stock declined 29.11% while stock markets rallied. The hedge fund held 566,100 shares of the mining & quarrying of nonmetallic minerals (no fuels) company at the end of 2017Q2, valued at $6.14M, up from 421,700 at the end of the previous reported quarter. Oceanic Investment Management Ltd who had been investing in Hi for a number of months, seems to be bullish on the $883.00M market cap company. The stock declined 1.03% or $0.1 reaching $9.6 on the news. About 1,902 shares traded. Hi-Crush Partners LP (NYSE:HCLP) has risen 114.79% since November 15, 2016 and is uptrending. It has outperformed by 98.09% the S&P500.

Temasek Holdings Private Ltd decreased its stake in Thermo Fisher Scientific Inc (TMO) by 6.91% based on its latest 2017Q2 regulatory filing with the SEC. Temasek Holdings Private Ltd sold 111,600 shares as the company’s stock rose 8.13% with the market. The institutional investor held 1.50M shares of the industrial machinery and components company at the end of 2017Q2, valued at $262.24 million, down from 1.61M at the end of the previous reported quarter. Temasek Holdings Private Ltd who had been investing in Thermo Fisher Scientific Inc for a number of months, seems to be less bullish one the $75.42 billion market cap company. The stock rose 2.39% or $4.51 reaching $193.59. About 10,030 shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 15.57% since November 15, 2016 and is uptrending. It has underperformed by 1.13% the S&P500.

Analysts await Thermo Fisher Scientific Inc. (NYSE:TMO) to report earnings on January, 30. They expect $2.67 earnings per share, up 10.79% or $0.26 from last year’s $2.41 per share. TMO’s profit will be $1.04B for 18.13 P/E if the $2.67 EPS becomes a reality. After $2.31 actual earnings per share reported by Thermo Fisher Scientific Inc. for the previous quarter, Wall Street now forecasts 15.58% EPS growth.

Since May 24, 2017, it had 0 insider purchases, and 3 sales for $4.70 million activity. CASPER MARC N had sold 20,000 shares worth $3.46M. On Monday, June 5 Williamson Stephen sold $440,650 worth of Thermo Fisher Scientific Inc. (NYSE:TMO) or 2,500 shares.

Investors sentiment decreased to 0.91 in Q2 2017. Its down 0.04, from 0.95 in 2017Q1. It is negative, as 43 investors sold TMO shares while 415 reduced holdings. 99 funds opened positions while 316 raised stakes. 323.23 million shares or 1.69% less from 328.77 million shares in 2017Q1 were reported. 191,081 were reported by Confluence Mgmt Limited. Massachusetts-based Aureus Asset Mngmt Ltd Com has invested 2.54% in Thermo Fisher Scientific Inc. (NYSE:TMO). 219,079 are owned by Bankshares. Exchange Cap Mgmt has 42 shares for 0% of their portfolio. First American Bankshares holds 26,770 shares or 0.37% of its portfolio. Welch & Forbes Limited Liability Company holds 0.06% or 12,148 shares in its portfolio. Cleararc Capital Inc invested in 0.25% or 8,872 shares. Gabelli Funds Ltd Liability Com reported 145,500 shares. National Registered Investment Advisor owns 8,816 shares. Reinhart holds 0.06% or 3,430 shares in its portfolio. Everence Mgmt reported 11,235 shares. Boston Family Office Limited holds 22,062 shares or 0.46% of its portfolio. Wetherby Asset Management invested in 6,169 shares or 0.18% of the stock. Northeast Consultants reported 5,500 shares stake. Hl Svcs Ltd Liability Company reported 4,635 shares.

Temasek Holdings Private Ltd, which manages about $15.51B US Long portfolio, upped its stake in Royal Dutch Shell Plc by 2.04 million shares to 2.45 million shares, valued at $133.35 million in 2017Q2, according to the filing.

More notable recent Thermo Fisher Scientific Inc. (NYSE:TMO) news were published by: Prnewswire.com which released: “Thermo Fisher Scientific Declares Quarterly Dividend” on November 09, 2017, also Investorplace.com with their article: “Earnings Visibility Keep Thermo Fisher Scientific (TMO) a Buy” published on November 09, 2017, Prnewswire.com published: “Thermo Fisher Scientific Signs Oncology Companion Diagnostic Development …” on October 31, 2017. More interesting news about Thermo Fisher Scientific Inc. (NYSE:TMO) were released by: Prnewswire.com and their article: “Thermo Fisher Scientific Customers to Showcase Innovations in Precision …” published on October 17, 2017 as well as Globenewswire.com‘s news article titled: “Thermo Fisher Scientific and Cellular Biomedicine Group Announce Strategic …” with publication date: November 06, 2017.

Among 17 analysts covering Thermo Fisher Scientific (NYSE:TMO), 16 have Buy rating, 0 Sell and 1 Hold. Therefore 94% are positive. Thermo Fisher Scientific had 50 analyst reports since July 24, 2015 according to SRatingsIntel. The company was maintained on Tuesday, May 3 by Mizuho. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) has “Outperform” rating given on Monday, October 9 by Leerink Swann. The rating was maintained by Leerink Swann with “Buy” on Friday, April 28. As per Monday, January 11, the company rating was maintained by Stifel Nicolaus. The stock has “Overweight” rating by JP Morgan on Thursday, September 22. Jefferies maintained Thermo Fisher Scientific Inc. (NYSE:TMO) on Wednesday, September 27 with “Hold” rating. The stock has “Buy” rating by Cowen & Co on Wednesday, October 11. Jefferies maintained the shares of TMO in report on Tuesday, August 22 with “Hold” rating. Barclays Capital maintained the shares of TMO in report on Tuesday, July 19 with “Overweight” rating. The firm earned “Neutral” rating on Friday, September 9 by Cleveland.

More important recent Hi-Crush Partners LP (NYSE:HCLP) news were published by: Globenewswire.com which released: “Hi-Crush Partners LP Reports Third Quarter 2017 Results” on October 31, 2017, also Globenewswire.com published article titled: “Hi-Crush Partners LP Resumes Distribution for the Third Quarter of 2017 and …”, Seekingalpha.com published: “Hi-Crush Partners LP (HCLP) Q3 2017 Results – Earnings Call Transcript” on November 01, 2017. More interesting news about Hi-Crush Partners LP (NYSE:HCLP) was released by: Seekingalpha.com and their article: “Hi-Crush Partners Making All The Right Moves” with publication date: October 19, 2017.

Investors sentiment decreased to 1.66 in Q2 2017. Its down 0.41, from 2.07 in 2017Q1. It fall, as 22 investors sold HCLP shares while 16 reduced holdings. 27 funds opened positions while 36 raised stakes. 44.46 million shares or 4.19% less from 46.41 million shares in 2017Q1 were reported. Jpmorgan Chase Co owns 337,231 shares for 0% of their portfolio. Da Davidson Co holds 0% of its portfolio in Hi-Crush Partners LP (NYSE:HCLP) for 1,525 shares. Malaga Cove owns 65,298 shares for 0.43% of their portfolio. Jefferies Gru Ltd Liability Corporation holds 0% or 62,500 shares in its portfolio. Us Bank & Trust De reported 1,800 shares stake. Peconic Prtn Ltd Liability Company owns 107,380 shares for 0.19% of their portfolio. Goldman Sachs Gru invested in 3.71 million shares. Group Inc One Trading Ltd Partnership accumulated 101,979 shares. Lafitte Management LP has invested 7.94% in Hi-Crush Partners LP (NYSE:HCLP). Wells Fargo & Mn has 0% invested in Hi-Crush Partners LP (NYSE:HCLP). 12,467 were reported by Hightower Advsr Ltd Limited Liability Company. Cushing Asset Mngmt Limited Partnership has 0.18% invested in Hi-Crush Partners LP (NYSE:HCLP) for 488,280 shares. Selz Cap Lc accumulated 200,079 shares. Next Fincl Group holds 0% of its portfolio in Hi-Crush Partners LP (NYSE:HCLP) for 13,575 shares. Bank & Trust Of Montreal Can holds 0.03% of its portfolio in Hi-Crush Partners LP (NYSE:HCLP) for 2.83 million shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts